The biology of human interleukin-32

Contemporary Targeted Therapies in Rheumatology

Volumn , Issue , 2007, Pages 225-230

  Dinarello, Charles A ^a   Kim, Soo Hyun ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36549085254     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (14)

1. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: A cytokine and inducer of TNFalpha. Immunity 2005; 22(1): 131-42.
2. Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992; 148(2): 597-603.
3. Carter KL, Cahir-McFarland E, Kieff E. Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J Virol 2002; 76(20): 10427-36.
4. Park GH, Choe J, Choo HJ et al. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray. Exp Mol Med2002; 34(3): 184-93.
5. Brown J, Matutes E, Singleton A et al. Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinase. Leukemia 1998; 12(11): 1771-81.
6. Goda C, Kanaji T, Kanaji S et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol2006; 18(2): 233-40.
7. Novick D, Rubinstein M, Azam T et al. Proteinase 3 is an interleukin-32 binding protein. Proc Natl Acad Sci U S A 2006; 103: 3316-21.
8. Netea MG, Azam T, Lewis EC et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 2006; 3(8): e277.
9. Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG et al.Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 2002; 32(1): 97-105.
10. Dayer JM, Graham R, Russell G, Krane SM. Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science 1977; 195(4274): 181-3.
11. Cagnard N, Letourneur F, Essabbani A et al.Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblastlike synoviocytes. Eur Cytokine Netw 2005; 16(4): 289-92.
12. Joosten LA, Netea MG, Kim SH et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 2006; 103(9): 3298-303.
13. Shoda H, Fujio K, Yamaguchi Y et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006; 8(6): R166.
14. Netea MG, Azam T, Ferwerda G et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1 β and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A 2005; 102(45): 16309-14.